224 related articles for article (PubMed ID: 37523561)
21. HPV Meets APOBEC: New Players in Head and Neck Cancer.
Riva G; Albano C; Gugliesi F; Pasquero S; Pacheco SFC; Pecorari G; Landolfo S; Biolatti M; Dell'Oste V
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573337
[TBL] [Abstract][Full Text] [Related]
22.
Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
[TBL] [Abstract][Full Text] [Related]
23. CENPM upregulation by E5 oncoprotein of human papillomavirus promotes radiosensitivity in head and neck squamous cell carcinoma.
Liu T; Ma L; Song L; Yan B; Zhang S; Wang B; Zuo N; Sun X; Deng Y; Ren Q; Li Y; Zhou J; Liu Q; Wei L
Oral Oncol; 2022 Jun; 129():105858. PubMed ID: 35462155
[TBL] [Abstract][Full Text] [Related]
24. Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.
Chung CH; Guthrie VB; Masica DL; Tokheim C; Kang H; Richmon J; Agrawal N; Fakhry C; Quon H; Subramaniam RM; Zuo Z; Seiwert T; Chalmers ZR; Frampton GM; Ali SM; Yelensky R; Stephens PJ; Miller VA; Karchin R; Bishop JA
Ann Oncol; 2015 Jun; 26(6):1216-1223. PubMed ID: 25712460
[TBL] [Abstract][Full Text] [Related]
25. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
[TBL] [Abstract][Full Text] [Related]
26. Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways.
Yang X; Cheng H; Chen J; Wang R; Saleh A; Si H; Lee S; Guven-Maiorov E; Keskin O; Gursoy A; Nussinov R; Fang J; Van Waes C; Chen Z
Cancer Immunol Res; 2019 Nov; 7(11):1760-1774. PubMed ID: 31624067
[TBL] [Abstract][Full Text] [Related]
27. NRF2, p53, and p16: Predictive biomarkers to stratify human papillomavirus associated head and neck cancer patients for de-escalation of cancer therapy.
Ramesh PS; Devegowda D; Singh A; Thimmulappa RK
Crit Rev Oncol Hematol; 2020 Apr; 148():102885. PubMed ID: 32062315
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
29. Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma.
Ida S; Takahashi H; Tada H; Mito I; Matsuyama T; Chikamatsu K
Oral Oncol; 2023 Feb; 137():106296. PubMed ID: 36571985
[TBL] [Abstract][Full Text] [Related]
30. Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1.
Beck TN; Smith CH; Flieder DB; Galloway TJ; Ridge JA; Golemis EA; Mehra R
Head Neck; 2017 Mar; 39(3):E34-E39. PubMed ID: 27859938
[TBL] [Abstract][Full Text] [Related]
31. Identification of hub genes and potential therapeutic mechanisms related to HPV positive head and neck squamous carcinoma based on full transcriptomic detection and ceRNA network construction.
Wang K; Zhang T; Li X; Zhang X; Li R; Pan B; Deng J
Gene; 2024 Jun; 910():148321. PubMed ID: 38428621
[TBL] [Abstract][Full Text] [Related]
32. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
[TBL] [Abstract][Full Text] [Related]
33. Immune landscape in molecular subtypes of human papillomavirus-negative head and neck cancer.
Xie M; Chaudhary R; Slebos RJC; Lee K; Song F; Poole MI; Hoening DS; Noel LC; Hernandez-Prera JC; Conejo-Garcia JR; Chung CH; Tan AC
Mol Carcinog; 2024 Jan; 63(1):120-135. PubMed ID: 37750589
[TBL] [Abstract][Full Text] [Related]
34. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
Li J; Tang LL; Ma J
BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
[TBL] [Abstract][Full Text] [Related]
35. Preferential activation of the hedgehog pathway by epigenetic modulations in HPV negative HNSCC identified with meta-pathway analysis.
Fertig EJ; Markovic A; Danilova LV; Gaykalova DA; Cope L; Chung CH; Ochs MF; Califano JA
PLoS One; 2013; 8(11):e78127. PubMed ID: 24223768
[TBL] [Abstract][Full Text] [Related]
36. Biological basis for increased sensitivity to radiation therapy in HPV-positive head and neck cancers.
Bol V; Grégoire V
Biomed Res Int; 2014; 2014():696028. PubMed ID: 24804233
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass.
van Harten AM; Poell JB; Buijze M; Brink A; Wells SI; René Leemans C; Wolthuis RMF; Brakenhoff RH
Oral Oncol; 2019 Nov; 98():53-61. PubMed ID: 31541927
[TBL] [Abstract][Full Text] [Related]
38. Biomarkers of radioresistance in head and neck squamous cell carcinomas.
Avril D; Foy JP; Bouaoud J; Grégoire V; Saintigny P
Int J Radiat Biol; 2023; 99(4):583-593. PubMed ID: 35930497
[TBL] [Abstract][Full Text] [Related]
39. 5-Hydroxymethylation highlights the heterogeneity in keratinization and cell junctions in head and neck cancers.
Liu S; de Medeiros MC; Fernandez EM; Zarins KR; Cavalcante RG; Qin T; Wolf GT; Figueroa ME; D'Silva NJ; Rozek LS; Sartor MA
Clin Epigenetics; 2020 Nov; 12(1):175. PubMed ID: 33203436
[TBL] [Abstract][Full Text] [Related]
40. HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers.
Koneva LA; Zhang Y; Virani S; Hall PB; McHugh JB; Chepeha DB; Wolf GT; Carey TE; Rozek LS; Sartor MA
Mol Cancer Res; 2018 Jan; 16(1):90-102. PubMed ID: 28928286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
